Rheumatology

Guidelines (9)

Certolizumab Pegol for Treating Rheumatoid Arthritis after Inadequate Response to a TNF-Alpha Inhibitor (TA415)

26 October 2016

Care and Management of Osteoarthritis in Adults (NICE Guideline)

15 March 2014

Summary of NICE guidance on OA assessment and treatment.

Pegloticase for Treating Severe Debilitating Chronic Tophaceous Gout (TA291)

26 June 2013

Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)

24 April 2013

Denosumab for the Treatment of Therapy-Induced Bone Loss in Non-Metastatic Prostate Cancer (terminated appraisal) (TA194)

24 January 2013

Denosumab for the Prevention of Skeletal-Related Events in Adults with Bone Metastases from Solid Tumours (TA265)

24 October 2012

Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)

26 March 2012

Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women (TA204)

31 October 2010

Febuxostat for the Management of Hyperuricaemia in People with Gout (TA164)

14 April 2010

Tables (1)

Table: Calcium and Vitamin D Supplements for Osteoporosis

3 January 2018

Formulations, doses and costs of osteoporosis supplements.

Drug Sections (6)

Rheumatology in the News

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

By Chloe Harman, 1 December 2017

NHS England believes cutting access to the treatments,...

Arthritis biologic approved for NHS prescribing

By Chloe Harman, 3 November 2017

Sarilumab (Kevzara) is to be funded on the NHS, following...

Tofacitinib approved by NICE for severe rheumatoid arthritis

By Sandhiya Sodha, 12 October 2017

The JAK inhibitor tofacitinib (Xeljanz) has been endorsed...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more

Mims

Browse news and resources by disease area